NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,133,000 | +1.8% | 3,018,953 | +33.0% | 0.05% | +11.9% |
Q2 2023 | $36,480,000 | +3.5% | 2,270,053 | +12.1% | 0.04% | 0.0% |
Q1 2023 | $35,244,000 | +93.8% | 2,024,354 | +2.8% | 0.04% | +100.0% |
Q4 2022 | $18,190,000 | +10.1% | 1,968,574 | +2.6% | 0.02% | +5.0% |
Q3 2022 | $16,524,000 | +7.6% | 1,918,276 | +1.8% | 0.02% | +17.6% |
Q2 2022 | $15,363,000 | -36.5% | 1,885,014 | -5.3% | 0.02% | -5.6% |
Q1 2022 | $24,186,000 | -48.8% | 1,990,607 | +43.8% | 0.02% | -53.8% |
Q4 2021 | $47,242,000 | -52.1% | 1,384,604 | -32.2% | 0.04% | -53.6% |
Q3 2021 | $98,528,000 | +150.2% | 2,042,456 | +134.3% | 0.08% | +162.5% |
Q2 2021 | $39,375,000 | +21183.8% | 871,711 | +22636.3% | 0.03% | – |
Q1 2021 | $185,000 | -18.5% | 3,834 | -9.1% | 0.00% | – |
Q4 2020 | $227,000 | +45.5% | 4,219 | 0.0% | 0.00% | – |
Q3 2020 | $156,000 | +19.1% | 4,219 | 0.0% | 0.00% | – |
Q2 2020 | $131,000 | +48.9% | 4,219 | +33.0% | 0.00% | – |
Q1 2020 | $88,000 | +700.0% | 3,173 | +267.7% | 0.00% | – |
Q4 2018 | $11,000 | – | 863 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |